Stryker Corporation (LON:0R2S)
London
· Delayed Price · Currency is GBP · Price in USD | Market Cap | 106.76B |
| Revenue (ttm) | 17.38B |
| Net Income (ttm) | 2.13B |
| Shares Out | n/a |
| EPS (ttm) | 5.51 |
| PE Ratio | 50.13 |
| Forward PE | 26.59 |
| Dividend | 2.53 (0.67%) |
| Ex-Dividend Date | Jun 30, 2025 |
| Volume | 258 |
| Average Volume | 262 |
| Open | 378.26 |
| Previous Close | 375.20 |
| Day's Range | 374.93 - 378.50 |
| 52-Week Range | 323.66 - 406.70 |
| Beta | 0.99 |
| RSI | 38.02 |
| Earnings Date | Jul 31, 2025 |
About Stryker
Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke,... [Read more]
Financial Performance
In 2024, Stryker's revenue was $22.60 billion, an increase of 10.23% compared to the previous year's $20.50 billion. Earnings were $2.99 billion, a decrease of -5.43%.
Financial numbers in USD Financial StatementsNews
This Is What Whales Are Betting On Stryker
Whales with a lot of money to spend have taken a noticeably bullish stance on Stryker . Looking at options history for Stryker (NYSE: SYK) we detected 8 trades. If we consider the specifics of each t...
Sell Alert: Ronda E Stryker Cashes Out $75.29M In Stryker Stock
Making a noteworthy insider sell on August 7, Ronda E Stryker , Director at Stryker (NYSE: SYK), is reported in the latest SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exch...
Tim Scannell, Former Stryker President & COO, Named Chair of Longeviti Neuro Solutions Amid $10M Capital Infusion From Soleus Capital
BALTIMORE, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Longeviti Neuro Solutions, a neurotechnology company with a focus on innovative platform solutions for complex brain disorders, today announces the appoint...
Stryker declares an $0.84 per share quarterly dividend
Portage, Michigan, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.84 per share payable October 31, 2025, to sharehol...
Stryker (SYK) Q2 2025 Earnings Call Transcript
Stryker (SYK) Q2 Revenue Jumps 11%
Stryker raises 2025 organic sales growth outlook to 9.5%-10% as strong demand drives margin expansion
Stryker Corporation (SYK) Q2 2025 Earnings Call Transcript
Stryker Lifts Guidance on Improving Tariff Outlook
Stryker raises annual profit forecast on steady demand for surgical devices
Stryker raised its annual profit forecast and beat quarterly profit estimates on Thursday, banking on strong demand for its medical and surgical devices.
Stryker reports second quarter 2025 operating results
Portage, Michigan, July 31, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the second quarter of 2025: Second Quarter Results Reported net sales increased 11.1% to $6.0 bil...
10 stocks favored to gain up to 30% in a sector that has missed this year's rally
All but two of the S&P 500's sectors are up so far in 2025.
Paul MacDonald's Top Picks: Stryker, Abbott Labs & Elevance Health
Paul MacDonald, Chief Investment Officer & Portfolio Manager at Harvest Portfolios Group, shares his top stock picks to watch in the market.
Ventas, Stryker Corporation & Chartwell: Neela White's stock investment picks
Neela White, Senior Portfolio Manager at Blue Wing Advisory Group, Raymond James, joins BNN Bloomberg to discuss investing strategy.
Inari Medical, now part of Stryker, launches the all-new InThrill® Thrombectomy System, designed to address arteriovenous access and small vessel thrombus cases
PORTAGE, Mich. , July 29, 2025 /PRNewswire/ -- Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its next-generation InThrill Thrombectom...
A Look Into Stryker Inc's Price Over Earnings
In the current session, the stock is trading at $397.65, after a 0.25% increase. Over the past month, Stryker Inc. (NYSE: SYK) stock increased by 2.28% , and in the past year, by 20.52% . With perfor...
Rep. Thomas Kean Has Sold Up to $65K Worth Of Stryker Stock: Here's What You Should Know
A July filing shows that Representative Thomas Kean reported a sale in Stryker (NYSE: SYK), valued between $16,002 and $65,000. The transaction date is listed as June 26, 2025, with the report publis...
Looking Into Stryker's Recent Short Interest
Stryker's (NYSE: SYK) short percent of float has risen 12.86% since its last report. The company recently reported that it has 5.74 million shares sold short , which is 1.58% of all regular shares th...
North America Cystoscopes Market Outlook Report 2025-2033 Featuring Key Companies - Olympus, KARL STORZ, Stryker, PENTAX Medical, Richard Wolf, Ambu, Laborie Medical Technologies
Discover comprehensive insights with the "North America Cystoscopes Market Outlook to 2033" report. Analyze market data, company shares, and segment details for Flexible and Rigid Cystoscopes. Develop...
Cathie Wood Vs. Jim Cramer: TV Host Says Top Ark AI Pick 'Losing Money Hand Over Fist'
When it comes to artificial intelligence stocks , there are multiple that are found in the various portfolios of Ark Funds, led by Cathie Wood. One of Wood's favorite AI stocks has been criticized by ...
Here's How Much You Would Have Made Owning Stryker Stock In The Last 5 Years
Stryker (NYSE: SYK) has outperformed the market over the past 5 years by 2.18% on an annualized basis producing an average annual return of 16.79%. Currently, Stryker has a market capitalization of $...
Stryker to announce financial results for its second quarter of fiscal year 2025
Portage, Michigan, July 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its second quarter of fiscal year 2025 on Thursday, July 31, 2025. A press ...
US stocks threatens to close at record levels but closes just off record levels
The broader stock indices threatened to close at record levels with the S&P index getting within one point of a record high level. The comes in at 6147.43. The high price today reached 6146.52. The NA...
The Big 3: NXT, ANET, SYK
Today's trading action added confidence to Dan Deming's perception on the markets, noting widening market breadth as a healthy sign for price action. On individual stocks, he sees growth opportunities...
Stryker receives FDA clearance for Incompass Total Ankle System
PORTAGE, Mich.--(BUSINESS WIRE)--Stryker received FDA 510(k) clearance for its Incompass® Total Ankle System, intended for patients with severe arthritis-related ankle joint damage.